Fernando Rivera

3.5k total citations · 1 hit paper
43 papers, 2.5k citations indexed

About

Fernando Rivera is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Fernando Rivera has authored 43 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Fernando Rivera's work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Genomics and Diagnostics (7 papers) and Reproductive Physiology in Livestock (7 papers). Fernando Rivera is often cited by papers focused on Colorectal Cancer Treatments and Studies (10 papers), Cancer Genomics and Diagnostics (7 papers) and Reproductive Physiology in Livestock (7 papers). Fernando Rivera collaborates with scholars based in Spain, United States and France. Fernando Rivera's co-authors include Thierry André, Josep Tabernero, John Bridgewater, Matilde Navarro, C. Boni, Philip R. Clingan, Aimery de Gramont, Andrea Bonetti, C. Topham and Tamas Hickish and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

Fernando Rivera

42 papers receiving 2.4k citations

Hit Papers

Improved Overall Survival With Oxaliplatin, Fluorouracil,... 2009 2026 2014 2020 2009 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
    2009 1.6k citations Thierry André, Josep Tabernero et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fernando Rivera Spain 13 1.7k 568 470 454 371 43 2.5k
James E. Wheeler United States 27 392 0.2× 332 0.6× 369 0.8× 193 0.4× 347 0.9× 61 2.2k
Stuart Robinson United Kingdom 20 506 0.3× 417 0.7× 72 0.2× 196 0.4× 70 0.2× 62 1.4k
Veena Singh India 20 694 0.4× 247 0.4× 397 0.8× 218 0.5× 74 0.2× 65 1.9k
Peyton T. Taylor United States 29 597 0.3× 673 1.2× 226 0.5× 198 0.4× 52 0.1× 72 2.2k
Giacomo Corrado Italy 34 512 0.3× 1.1k 1.9× 142 0.3× 315 0.7× 87 0.2× 179 3.3k
Wei Han China 25 520 0.3× 206 0.4× 76 0.2× 102 0.2× 86 0.2× 156 2.4k
Yahya Daneshbod Iran 21 739 0.4× 341 0.6× 280 0.6× 397 0.9× 36 0.1× 101 1.8k
Michael Chiorean United States 21 214 0.1× 850 1.5× 78 0.2× 222 0.5× 747 2.0× 94 1.9k
Randi E. Gislefoss Norway 26 338 0.2× 283 0.5× 121 0.3× 107 0.2× 93 0.3× 46 1.6k

Countries citing papers authored by Fernando Rivera

Since Specialization
Citations

This map shows the geographic impact of Fernando Rivera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Rivera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Rivera more than expected).

Fields of papers citing papers by Fernando Rivera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Rivera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Rivera. The network helps show where Fernando Rivera may publish in the future.

Co-authorship network of co-authors of Fernando Rivera

This figure shows the co-authorship network connecting the top 25 collaborators of Fernando Rivera. A scholar is included among the top collaborators of Fernando Rivera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fernando Rivera. Fernando Rivera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marzolini, Susan, Paul Oh, James E. Peterman, et al.. (2024). Sex Differences and Correlates of the Utility of the Cardiopulmonary Exercise Test for Prescribing Exercise at Entry to Cardiac Rehabilitation. Canadian Journal of Cardiology. 41(3). 481–490. 1 indexed citations
2.
Elez, Élena, Cristina Grávalos, Pilar García‐Alfonso, et al.. (2023). A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients. Biomedicine & Pharmacotherapy. 159. 114272–114272. 8 indexed citations
3.
Munipalli, Bala, et al.. (2022). Association of Vitamin B12, Vitamin D, and Thyroid-Stimulating Hormone With Fatigue and Neurologic Symptoms in Patients With Fibromyalgia. SHILAP Revista de lepidopterología. 6(4). 381–387. 9 indexed citations
4.
Fernández‐Rodríguez, Concepción, Vicente Alonso Orduña, Ferrán Losa, et al.. (2022). P-118 Cetuximab rechallenge in RAS, BRAF, EGFR-ECD wild type metastatic colorectal cancer (mCRC) patients treated with anti-EGFR therapies in first line: The CITRIC study. Annals of Oncology. 33. S291–S291. 7 indexed citations
5.
6.
7.
Goldman, Aaron, et al.. (2012). Abstract 27: Chemotherapy-induced Akt survival signaling is regulated by CD44- Ezrin/Radaxin Moesin (ERM) scaffolding, dependent on EGFR activity. Cancer Research. 72(8_Supplement). 27–27. 1 indexed citations
8.
Rasmussen, Keith G., et al.. (2011). The Safety of Electroconvulsive Therapy in Patients With Prolonged QTc Intervals on the Electrocardiogram. Journal of Ect. 27(3). 192–200. 10 indexed citations
9.
Cerri, R.L.A., R.C. Chebel, Fernando Rivera, et al.. (2011). Concentration of progesterone during the development of the ovulatory follicle: II. Ovarian and uterine responses. Journal of Dairy Science. 94(7). 3352–3365. 119 indexed citations
10.
Cerri, R.L.A., R.C. Chebel, Fernando Rivera, et al.. (2011). Concentration of progesterone during the development of the ovulatory follicle: I. Ovarian and embryonic responses. Journal of Dairy Science. 94(7). 3342–3351. 65 indexed citations
11.
Gómez-Martín, Carlos, Ángel Concha, Tomás García‐Caballero, et al.. (2011). Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma. Clinical & Translational Oncology. 13(9). 636–651. 13 indexed citations
12.
Santos, J.E.P., C.D. Narciso, Fernando Rivera, W.W. Thatcher, & R.C. Chebel. (2010). Effect of reducing the period of follicle dominance in a timed artificial insemination protocol on reproduction of dairy cows. Journal of Dairy Science. 93(7). 2976–2988. 132 indexed citations
13.
Rivera, Fernando, C.D. Narciso, Ruan Oliveira, et al.. (2010). Effect of bovine somatotropin (500 mg) administered at ten-day intervals on ovulatory responses, expression of estrus, and fertility in dairy cows. Journal of Dairy Science. 93(4). 1500–1510. 35 indexed citations
14.
Ko, Amy, Josep Tabernero, Fernando Rivera, et al.. (2010). Phase II study of telatinib (T) in combination with capecitabine (X) and cisplatin (P) as first-line treatment in patients (pts) with advanced cancer of the stomach (G) or gastro-esophageal junction (GEJ).. Journal of Clinical Oncology. 28(15_suppl). e14575–e14575. 5 indexed citations
15.
Rivera, Fernando, et al.. (2004). Aspectos psicológicos de la toxicidad de la quimioterapia. SHILAP Revista de lepidopterología. 3 indexed citations
16.
Rivera, Fernando, et al.. (1996). Intermediate filament aggregates in mitoses of primary cutaneous neuroendocrine (Merkel cell) carcinoma. Histopathology. 28(4). 349–355. 12 indexed citations
17.
Mayordomo, José, Fernando Rivera, P. Lianes, et al.. (1995). Improving Treatment of Chemotherapy-Induced Neutropenic Fever by Administration of Colony-Stimulating Factors. JNCI Journal of the National Cancer Institute. 87(11). 803–808. 100 indexed citations
18.
Balasch, Juan, Montserrat Creus, Francisco Fábregues, et al.. (1995). Hormonal profiles in successful and unsuccessful implantation in IVF–ET after combined GnRH agonist/gonadotropin treatment for superovulation and hCG luteal support. Gynecological Endocrinology. 9(1). 51–58. 16 indexed citations
19.
Mayordomo, José, Luis Paz‐Ares, Fernando Rivera, et al.. (1994). Ovarian and extragonadal malignant germ-cell tumors in females: A single-institution experience with 43 patients. Annals of Oncology. 5(3). 225–231. 43 indexed citations
20.
Paz‐Ares, Luis, et al.. (1993). CMV front-line chemotherapy in transitional bladder carcinoma. Annals of Oncology. 4(2). 147–150. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James E. Wheeler Breakdown of academic impact, for papers by Stuart Robinson Breakdown of academic impact, for papers by Veena Singh Breakdown of academic impact, for papers by Peyton T. Taylor Breakdown of academic impact, for papers by Giacomo Corrado Breakdown of academic impact, for papers by Wei Han Breakdown of academic impact, for papers by Yahya Daneshbod Breakdown of academic impact, for papers by Michael Chiorean Breakdown of academic impact, for papers by Randi E. Gislefoss
Rankless by CCL
2026